Retina transplants via donor iPS cells

Retina transplants via donor iPS cells

Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute. She said in Tokyo on April 18, 2019 that five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000156066
  • Registered date
  • 2019/4/18 03:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2019 Kyodo News
  • Media size
  • 564 × 800 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 92.88(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Renowned researcher leaves Riken institute

    Renowned researcher leaves Riken institute

    Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute who led a team that succeeded for the first time in the world in transplanting into a woman retinal cells grown from her own iPS cells in 2014. Riken announced on July 31, 2019, that Takahashi will leave the institute the same day. (Kyodo) ==Kyodo
      Retina transplants via donor iPS cells

      Retina transplants via donor iPS cells

      Masayo Takahashi, a researcher at the Japanese government-backed Riken institute, speaks at an academic conference in Tokyo on April 18, 2019. Five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors, she said. (Kyodo) ==Kyodo
        World's 1st test using iPS cells to treat corneal disease

        World's 1st test using iPS cells to treat corneal disease

        Osaka University professor Koji Nishida speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
          World's 1st test using iPS cells to treat corneal disease

          World's 1st test using iPS cells to treat corneal disease

          Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
            Obokata fails to file appeal after panel condemns "STAP cell" study

            Obokata fails to file appeal after panel condemns "STAP cell" study

            TOKYO, Japan - Photo shows Haruko Obokata, a former researcher with the Riken research institute. The institute said on Jan. 6, 2015, that Obokata has not filed an appeal in response to a panel investigation finding in December, 2014 that "STAP cells" she claimed to have created almost certainly did not exist. (Kyodo)
              Purported "STAP cells" likely came from embryonic stem cells

              Purported "STAP cells" likely came from embryonic stem cells

              TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21.
                Purported "STAP cells" likely came from embryonic stem cells

                Purported "STAP cells" likely came from embryonic stem cells

                TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21. (Kyodo)
                  Purported "STAP cells" likely came from embryonic stem cells

                  Purported "STAP cells" likely came from embryonic stem cells

                  TOKYO, Japan - Photo shows Haruko Obokata, a former researcher with the Riken research institute. A panel under the government-backed institute said Dec. 26, 2014, that the "STAP cells" that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21.
                    Institute concludes Obokata failed to replicate "STAP cell" creation

                    Institute concludes Obokata failed to replicate "STAP cell" creation

                    TOKYO, Japan - File photo taken in April 2014 shows Haruko Obokata, a researcher with the Riken institute, during a press conference at an Osaka hotel. On Dec. 19, 2014, Riken concluded that Obokata failed in experiments to produce stem cells that she previously claimed to have created.
                      Institute concludes Obokata failed to replicate "STAP cell" creation

                      Institute concludes Obokata failed to replicate "STAP cell" creation

                      TOKYO, Japan - File photo taken Jan. 28, 2014, shows Haruko Obokata, a researcher with the Riken institute, at her laboratory in the institute in Kobe, western Japan. On Dec. 19, 2014, Riken concluded that Obokata failed in experiments to produce stem cells that she previously claimed to have created.